Ownership history in Caption Management, LLC · 18 quarters on record
This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in RECURSION PHARMACEUTICALS IN (RXRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 40,000 | +10,000 | +33.3% | 0.00% | $164K | $4.09 |
| 2025 Q3 | REDUCED | 30,000 | -40,000 | -57.1% | 0.00% | $146K | $4.88 |
| 2025 Q3 | REDUCED | 70,000 | -1,082,000 | -93.9% | 0.00% | $342K | $4.88 |
| 2025 Q2 | ADDED | 1,152,000 | +1,112,000 | +2780.0% | 0.06% | $5.8M | $5.06 |
As of 2025 Q4 — sorted by position size